Mahmut Apaydın
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mahmut Apaydın has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Taner Demirci
SAKARYA ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Özden Özdemir Başer
Dokuz Eylül Üniversitesi
2 shared publications A. Sari
Afyonkarahisar Hlth Sci Univ, Dept Internal Med, Afyon, Turkey
1 shared publication- Abdullah Evren Yetişir
Department of Medical Oncology, Adana City Training and Research Hospital, University of Health Sciences, Adana 01230, Türkiye
1 shared publication - Abdullah Karakaya1 shared publication
- Adnan Mesut Dede
Clinic of General Surgery Bartın State Hospital Bartın Türkiye
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 616-625
Novel Noninvasive Indices for Distinguishing Graves’ Disease from Subacute Thyroiditis
Objectives: Graves’ disease (GD) and subacute thyroiditis (SAT) are common causes of thyrotoxicosis. Accurate differential diagnosis is essential because of the distinct treatment approaches for these conditions; however, distinguishing between them may be challenging in clinical practice. This study aimed to evaluate hemogram and thyroid hormone parameters as simple diagnostic tools for differentiating GD from SAT and to develop novel indices for differential diagnosis. Material and Methods: This retrospective study included 220 patients with GD, 148 patients with SAT, and 185 individuals in a control group. Parameters were compared between groups, and different indices derived from these laboratory measurements were calculated. Results: The FT4-to-FT3 ratio, neutrophil-to-lymphocyte ratio, monocyte-to-eosinophil ratio, and platelet counts were all significantly higher in the SAT group than in the GD group (p
- 14 October 2026
- Published by Hitit University in Hitit Medical Journal
- Vol. 8 (3) , 616-625
Open AccessNovel Noninvasive Indices for Distinguishing Graves’ Disease from Subacute Thyroiditis
Objectives: Graves’ disease (GD) and subacute thyroiditis (SAT) are common causes of thyrotoxicosis. Accurate differential diagnosis is essential because of the distinct treatment approaches for these conditions; however, distinguishing between them may be challenging in clinical practice. This study aimed to evaluate hemogram and thyroid hormone parameters as simple diagnostic tools for differentiating GD from SAT and to develop novel indices for differential diagnosis. Material and Methods: This retrospective study included 220 patients with GD, 148 patients with SAT, and 185 individuals in a control group. Parameters were compared between groups, and different indices derived from these laboratory measurements were calculated. Results: The FT4-to-FT3 ratio, neutrophil-to-lymphocyte ratio, monocyte-to-eosinophil ratio, and platelet counts were all significantly higher in the SAT group than in the GD group (p
- 20 August 2026
- Published by Academician Publishing
Olgular Eşliğinde Acil Tıp
- 20 August 2026
- Published by Academician Publishing
- p. 235-242
Graves Hastalığında Total Tiroidektomi Sonrası Cerrahi Stres ve Levotiroksin Tedavisinin Tetiklediği Akut Adrenal Kriz Olgusu
Tirotoksikoz, dolaşımdaki tiroid hormonlarının artmış düzeyi sonucu gelişen klinik bir sendromdur; en sık nedeni otoimmün bir hastalık olan Graves hastalığıdır. Bu olgu sunumunda, antitiroid ilaç yan etkileri nedeniyle terapötik plazma değişimi (plazmaferez) ve ardından total tiroidektomi uygulanan genç bir kadın hastada postoperatif dönemde gelişen primer adrenal yetmezlik tablosu ele alınmıştır. Olgumuz, otoimmün poliglandüler sendrom zemininde cerrahi stres ve levotiroksin tedavisinin tetiklediği dekompanse primer adrenal yetmezliğin klinik kriz tablosuna ilerleyişi açısından önemli tanısal ve yönetimsel çıkarımlar sunmaktadır.
- 20 August 2026
- Published by Academician Publishing
- p. 235-242
Graves Hastalığında Total Tiroidektomi Sonrası Cerrahi Stres ve Levotiroksin Tedavisinin Tetiklediği Akut Adrenal Kriz Olgusu
Tirotoksikoz, dolaşımdaki tiroid hormonlarının artmış düzeyi sonucu gelişen klinik bir sendromdur; en sık nedeni otoimmün bir hastalık olan Graves hastalığıdır. Bu olgu sunumunda, antitiroid ilaç yan etkileri nedeniyle terapötik plazma değişimi (plazmaferez) ve ardından total tiroidektomi uygulanan genç bir kadın hastada postoperatif dönemde gelişen primer adrenal yetmezlik tablosu ele alınmıştır. Olgumuz, otoimmün poliglandüler sendrom zemininde cerrahi stres ve levotiroksin tedavisinin tetiklediği dekompanse primer adrenal yetmezliğin klinik kriz tablosuna ilerleyişi açısından önemli tanısal ve yönetimsel çıkarımlar sunmaktadır.
- Open Access
- 28 July 2025
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 7 (4) , 436-441
Relationship between type 2 diabetes and oral health status
Aims: This prospective cross-sectional study aimed to compare the decayed, missing, filled teeth (DMFT) index values and dental caries prevalence of patients with type 2 diabetes mellitus (T2DM) to those of healthy individuals, and to examine the effect of inadequate glycemic control on DMFT and caries prevalence. Methods: T2DM patients were divided into two groups based on metabolic control: well-controlled (WC; HbA1c ≤7%) and poorly controlled (PC; HbA1c >7%). The clinical parameters assessed were the number of natural teeth, the coronal DMFT index, the simplified oral hygiene index (OHI-S), and body-mass index (BMI). Results: The DMFT index and number of filled teeth were similar between the WC and healthy control groups. In contrast, the PC group showed significantly higher values than both the WC and control groups. The highest DMFT index (14.38) was observed in the PC group, and the lowest (9.90) in the control group (p
- 28 July 2025
- Published by Anatolian Current Medical Journal in Anatolian Current Medical Journal
- Vol. 7 (4) , 436-441
Open AccessRelationship between type 2 diabetes and oral health status
Aims: This prospective cross-sectional study aimed to compare the decayed, missing, filled teeth (DMFT) index values and dental caries prevalence of patients with type 2 diabetes mellitus (T2DM) to those of healthy individuals, and to examine the effect of inadequate glycemic control on DMFT and caries prevalence. Methods: T2DM patients were divided into two groups based on metabolic control: well-controlled (WC; HbA1c ≤7%) and poorly controlled (PC; HbA1c >7%). The clinical parameters assessed were the number of natural teeth, the coronal DMFT index, the simplified oral hygiene index (OHI-S), and body-mass index (BMI). Results: The DMFT index and number of filled teeth were similar between the WC and healthy control groups. In contrast, the PC group showed significantly higher values than both the WC and control groups. The highest DMFT index (14.38) was observed in the PC group, and the lowest (9.90) in the control group (p
- 26 March 2025
- Published by Academician Publishing
- p. 147-152
Obezitenin Tanımı ve Tanı Yöntemleri
- Open Access
- 26 March 2025
- Published by Academician Publishing
Genel Cerrahi Dersleri Üçüncü Kitap Obezite ve Endokrin Hastalıkların Cerrahi Tedavi Prensipleri
Tiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Tansu ALTINTAŞ Tiroid Hastalıklarının Cerrahi Tedavisi Nihat GÜLAYDIN Tiroid Cerrahisine Bağlı Komplikasyonların Yönetimi Yusuf Emre AYTİN Oğuzhan Alp ÖZTÜRK Paratiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Serkan ADEMOĞLU Paratiroid Hastalıkları ve Cerrahi Tedavi Kıvılcım ORHUN ERDOĞAN Paratiroidektominin Postoperatif Komplikasyonları Mehmet Fatih EKİCİ Sürrenal Bez Yapısal Özellikleri ve Fonksiyonları Adnan Mesut DEDE Sürrenal Bez Cerrahi Hastalıkları ve Tedavileri İsa KARACA Sürrenal Bez Cerrahisine Bağlı Komplikasyonların Yönetimi Mümtaz ERAKIN Metabolik Cerrahi Fatih TÜRKOĞLU Murat ÇİLEKAR Obezitenin Tarihi Yüksel DOĞAN Obezitenin Tanımı ve Tanı Yöntemleri Mahmut APAYDIN Obezitenin Medikal Tedavisi Serdar GÖK Selvihan BEYSEL Obezite Cerrahisi ve Psikiyatri İlişkisi Mustafa Melih BİLGİ Obezite Cerrahisine Hazırlık; Anestezi Preoperatif Hazırlıklar Bilge Banu Taşdemir MECIT Obezite Cerrahisine Hazırlık – Obez Hastalarda Görülen Kardiyolojik Problemler, Preoperatif ve Postoperatif Takip Prensipleri Mehmet Hakan UZUN Serkan GÖKASLAN Obezite Cerrahisinde Ameliyat Öncesi ve Sonrasında Pulmoner Değerlendirme Şule ÇİLEKAR Obezite Cerrahisi ve Beslenme Reyhan ÇETİN Perioperatif Obezite Cerrahisinde Anestezi Prensipleri Tuba Berra Sarıtaş Obeziteye Yönelik Endoskopik İntragastrik Balon Uygulamaları Metehan AYDIN Khalig YAGUBLU Sezgin YILMAZ Obezite Cerrahi Tedavi Prensipleri Kübra ERTEKİN Mehlika BİLGİ KIRMACI Sleeve Gastrektomi Metehan AYDIN Sezgin Yılmaz Roux-N-Y Gastrik Bypass Murat ÇİLEKAR Minigastrik By-Pass (Tek Anastomozlu Gastrik By-Pass) Kenan BÜYÜKAŞIK Biliyopankreatik Diversiyon ve Duodenal Switch Murat KEĞİN Obezitenin Cerrahi/Endoskopik Tedavisi Sonrası Metabolik ve Nutrisyonel Destek Tedavisi Emre BALLI Abdullah KARAKAYA Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Radyodiagnostik Değerlendirilmesi- Perkütan İşlemler Medine BÖGE Çiğdem ÖZER GÖKASLAN Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Yönetimi Mehmet Nuri KOŞAR Obezite Cerrahisinde Revizyon Cerrahisinin Yeri Murat AKICI Çocuk ve Ergen Obezite Tedavisinde Endoskopik ve Cerrahi Yaklaşımlar Çiğdem ARSLAN ALICI Ahmet Ali TUNCER Pankreas’ın Yapısal Özellikleri ve Fonksiyonları Burak Öztop Pankreasın Endokrin Tümörleri Mehlika BİLGİ KIRMACI Esat Taylan UĞURLU Bariyatrik Cerrahi Sonrası Vücut Şekillendirme Ameliyatları Salih Kavuncu
- 26 March 2025
- Published by Academician Publishing
Open AccessGenel Cerrahi Dersleri Üçüncü Kitap Obezite ve Endokrin Hastalıkların Cerrahi Tedavi Prensipleri
Tiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Tansu ALTINTAŞ Tiroid Hastalıklarının Cerrahi Tedavisi Nihat GÜLAYDIN Tiroid Cerrahisine Bağlı Komplikasyonların Yönetimi Yusuf Emre AYTİN Oğuzhan Alp ÖZTÜRK Paratiroid Bezinin Yapısal Özellikleri ve Fonksiyonları Serkan ADEMOĞLU Paratiroid Hastalıkları ve Cerrahi Tedavi Kıvılcım ORHUN ERDOĞAN Paratiroidektominin Postoperatif Komplikasyonları Mehmet Fatih EKİCİ Sürrenal Bez Yapısal Özellikleri ve Fonksiyonları Adnan Mesut DEDE Sürrenal Bez Cerrahi Hastalıkları ve Tedavileri İsa KARACA Sürrenal Bez Cerrahisine Bağlı Komplikasyonların Yönetimi Mümtaz ERAKIN Metabolik Cerrahi Fatih TÜRKOĞLU Murat ÇİLEKAR Obezitenin Tarihi Yüksel DOĞAN Obezitenin Tanımı ve Tanı Yöntemleri Mahmut APAYDIN Obezitenin Medikal Tedavisi Serdar GÖK Selvihan BEYSEL Obezite Cerrahisi ve Psikiyatri İlişkisi Mustafa Melih BİLGİ Obezite Cerrahisine Hazırlık; Anestezi Preoperatif Hazırlıklar Bilge Banu Taşdemir MECIT Obezite Cerrahisine Hazırlık – Obez Hastalarda Görülen Kardiyolojik Problemler, Preoperatif ve Postoperatif Takip Prensipleri Mehmet Hakan UZUN Serkan GÖKASLAN Obezite Cerrahisinde Ameliyat Öncesi ve Sonrasında Pulmoner Değerlendirme Şule ÇİLEKAR Obezite Cerrahisi ve Beslenme Reyhan ÇETİN Perioperatif Obezite Cerrahisinde Anestezi Prensipleri Tuba Berra Sarıtaş Obeziteye Yönelik Endoskopik İntragastrik Balon Uygulamaları Metehan AYDIN Khalig YAGUBLU Sezgin YILMAZ Obezite Cerrahi Tedavi Prensipleri Kübra ERTEKİN Mehlika BİLGİ KIRMACI Sleeve Gastrektomi Metehan AYDIN Sezgin Yılmaz Roux-N-Y Gastrik Bypass Murat ÇİLEKAR Minigastrik By-Pass (Tek Anastomozlu Gastrik By-Pass) Kenan BÜYÜKAŞIK Biliyopankreatik Diversiyon ve Duodenal Switch Murat KEĞİN Obezitenin Cerrahi/Endoskopik Tedavisi Sonrası Metabolik ve Nutrisyonel Destek Tedavisi Emre BALLI Abdullah KARAKAYA Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Radyodiagnostik Değerlendirilmesi- Perkütan İşlemler Medine BÖGE Çiğdem ÖZER GÖKASLAN Obezite ve Metabolik Sendrom Cerrahi Tedavi Sonrası Komplikasyonların Yönetimi Mehmet Nuri KOŞAR Obezite Cerrahisinde Revizyon Cerrahisinin Yeri Murat AKICI Çocuk ve Ergen Obezite Tedavisinde Endoskopik ve Cerrahi Yaklaşımlar Çiğdem ARSLAN ALICI Ahmet Ali TUNCER Pankreas’ın Yapısal Özellikleri ve Fonksiyonları Burak Öztop Pankreasın Endokrin Tümörleri Mehlika BİLGİ KIRMACI Esat Taylan UĞURLU Bariyatrik Cerrahi Sonrası Vücut Şekillendirme Ameliyatları Salih Kavuncu
- Open Access
- 1 December 2024
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 17, 6139-6144
Evaluation of Bone Health in Postmenopausal Women Using Long-Term Levothyroxine Treatment Due to Post-Procedural Hypothyroidism
Purpose: The connection between thyroid disorders and the health of bone is an endocrinological dilemma for physicians. Several studies have been conducted to examine the correlation between levothyroxine use and the risk of fracture. Different results have been obtained in these studies. The objective of the present study is to evaluate the impact of prolonged thyroid hormone replacement therapy on bone health in postmenopausal women. Patients and Methods: We obtained demographic data, laboratory results, and anthropometric measurements of patients from the hospital database. After the exclusion of patients, 59 patients with post-procedural hypothyroidism (n = 59) and a control group (n = 45) were evaluated. The patient group consisted of individuals who had undergone thyroid surgery for a benign condition and had been on levothyroxine treatment for a minimum of 5 years. Densitometric measurements of bone mass in the hip and spine were performed by bone mineral densitometry. Results: Groups were similar in age, PTH, vitamin D, bone-specific ALP, and BMI (p>0.05). The control group had a significantly lower total T score-F than the hypothyroidism group (-0.77 +/- 1.3 to -0.29 +/- 1.02, p= 0.041). However, total T score-LV, total gr/cm2-LV, and total gr/cm2-F were similar in both groups. Conclusion: This study showed that long-term levothyroxine therapy, which aims to maintain TSH levels within the normal reference range, is associated with increased bone mineral density (BMD) in postmenopausal women compared with the control group. Thus, to maintain bone health and prevent osteoporosis, it is important that postmenopausal women on long-term levothyroxine replacement undergo medical follow-up to prevent TSH suppression.
- 1 December 2024
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 17, 6139-6144
Open AccessEvaluation of Bone Health in Postmenopausal Women Using Long-Term Levothyroxine Treatment Due to Post-Procedural Hypothyroidism
Purpose: The connection between thyroid disorders and the health of bone is an endocrinological dilemma for physicians. Several studies have been conducted to examine the correlation between levothyroxine use and the risk of fracture. Different results have been obtained in these studies. The objective of the present study is to evaluate the impact of prolonged thyroid hormone replacement therapy on bone health in postmenopausal women. Patients and Methods: We obtained demographic data, laboratory results, and anthropometric measurements of patients from the hospital database. After the exclusion of patients, 59 patients with post-procedural hypothyroidism (n = 59) and a control group (n = 45) were evaluated. The patient group consisted of individuals who had undergone thyroid surgery for a benign condition and had been on levothyroxine treatment for a minimum of 5 years. Densitometric measurements of bone mass in the hip and spine were performed by bone mineral densitometry. Results: Groups were similar in age, PTH, vitamin D, bone-specific ALP, and BMI (p>0.05). The control group had a significantly lower total T score-F than the hypothyroidism group (-0.77 +/- 1.3 to -0.29 +/- 1.02, p= 0.041). However, total T score-LV, total gr/cm2-LV, and total gr/cm2-F were similar in both groups. Conclusion: This study showed that long-term levothyroxine therapy, which aims to maintain TSH levels within the normal reference range, is associated with increased bone mineral density (BMD) in postmenopausal women compared with the control group. Thus, to maintain bone health and prevent osteoporosis, it is important that postmenopausal women on long-term levothyroxine replacement undergo medical follow-up to prevent TSH suppression.
- 9 June 2022
- Published by Academician Publishing
Gebelikte Onkolojik Yaklaşımlar
Kadınlarda malign hastalıkların önemli bir kısmının üreme dönemlerinde teşhis ediliyor olduğu gerçeğinden hareketle gebeliğin onkoloji ile olan ilişkisi yadsınamaz bir durumdur. Gebelik ve kanser birlikteliği hem gebelik devam ederken hem de doğum sonrası dönemde tespit edilebilmektedir. Bu durumda onkolojik tedavi stratejilerinin nasıl kullanılabileceği, fetüsün ve anne sağlığının nasıl korunacağı hem onkoloji hem de kadın hastalıkları uzmanı hekimlerin ortak problemi olup multidisipliner yaklaşım gerektiren bir husustur. Şüphesiz kanser tedavisi hayati öneme haizdir ancak sosyokültürel faktörleri de göz önünde bulundurarak bireyselleştirilmiş tedavi yaklaşımı sergilemek oldukça önemlidir. Bu bilgiler doğrultusunda onkolojinin özel konularından olan Gebelik ve Kanser konulu bu kitabımızı ülkemizin değerli Kadın Hastalıkları ve Doğum, Tıbbi Onkoloji, Hematoloji, Radyasyon Onkolojisi, Genel Cerrahi, Beyin Cerrahisi, Patoloji, Tıbbi Genetik, Radyoloji, Nükleer Tıp, Anesteziyoloji, Psikiyatri ve Endokrinoloji alanında uzman ve akademik vizyonu olan hocalarımızın katkılarıyla hazırladık.
- 9 June 2022
- Published by Academician Publishing
Gebelikte Onkolojik Yaklaşımlar
Kadınlarda malign hastalıkların önemli bir kısmının üreme dönemlerinde teşhis ediliyor olduğu gerçeğinden hareketle gebeliğin onkoloji ile olan ilişkisi yadsınamaz bir durumdur. Gebelik ve kanser birlikteliği hem gebelik devam ederken hem de doğum sonrası dönemde tespit edilebilmektedir. Bu durumda onkolojik tedavi stratejilerinin nasıl kullanılabileceği, fetüsün ve anne sağlığının nasıl korunacağı hem onkoloji hem de kadın hastalıkları uzmanı hekimlerin ortak problemi olup multidisipliner yaklaşım gerektiren bir husustur. Şüphesiz kanser tedavisi hayati öneme haizdir ancak sosyokültürel faktörleri de göz önünde bulundurarak bireyselleştirilmiş tedavi yaklaşımı sergilemek oldukça önemlidir. Bu bilgiler doğrultusunda onkolojinin özel konularından olan Gebelik ve Kanser konulu bu kitabımızı ülkemizin değerli Kadın Hastalıkları ve Doğum, Tıbbi Onkoloji, Hematoloji, Radyasyon Onkolojisi, Genel Cerrahi, Beyin Cerrahisi, Patoloji, Tıbbi Genetik, Radyoloji, Nükleer Tıp, Anesteziyoloji, Psikiyatri ve Endokrinoloji alanında uzman ve akademik vizyonu olan hocalarımızın katkılarıyla hazırladık.
- 1 January 2022
- Vol. 26 (19) , 7182-7187
The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?
- OBJECTIVE: Polycystic ovary syndrome (PCOS) is the most common endo-crinological disorder in women of reproduc-tive age, often accompanied by high androgen levels, irregular menstrual cycles and polycys-tic ovaries. In addition, patients with PCOS al-so present with an increase in abdominal ad-ipose tissue and insulin resistance. Recently, the gender-specific mathematical formulation called visceral adiposity index (VAI) has been widely used in assessing cardiometabolic risk. This study aimed at comparing the VAI values of patients with PCOS, patients with idiopathic hir-sutism (IH) and a control group.PATIENTS AND METHODS: We obtained de-mographic data, laboratory results and anthro-pometric measurements of patients from the hospital database. We retrospectively grouped all cases included in the study as PCOS (n = 52), IH (n = 57) and control (n = 58) according to the diagnoses. We also took venous samples for hormone and biochemical tests in the early fol-licular phase of the menstrual cycle, at least 8-10 hours after fasting in the early morning hours. Finally, we evaluated the variables using SPSS 22.0 software (IBM Corp., Armonk, NY, USA).RESULTS: We included 167 female individu-als in the study. Of these, 57 (34.1%) were diag-nosed with IH, while 52 (31.1%) were diagnosed with PCOS. The control group comprised 58 (34.8%) healthy female individuals. The medi-an age of the study group was 25 years [inter -quartile range (IQR) = 8 years]. The age, height, weight, body mass index (BMI) and waist cir-cumference values of the groups were similar. We found that the VAI values among the groups were significantly different (p = 0.028). Post-hoc analysis determined that this was due to the dif-ference between the group with PCOS and the control group. In addition, we found significantly high HOMA-IR, fasting insulin and androgen levels in the group with PCOS (p < 0.001).CONCLUSIONS: After comparing data in groups with similar BMI levels, we found signifi-cantly high VAI values in patients with PCOS. The results reinforce the idea that VAI is a use-ful marker easily obtained in daily practice for assessing the cardiometabolic risk of patients with PCOS.
- 1 January 2022
- Vol. 26 (19) , 7182-7187
The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?
- OBJECTIVE: Polycystic ovary syndrome (PCOS) is the most common endo-crinological disorder in women of reproduc-tive age, often accompanied by high androgen levels, irregular menstrual cycles and polycys-tic ovaries. In addition, patients with PCOS al-so present with an increase in abdominal ad-ipose tissue and insulin resistance. Recently, the gender-specific mathematical formulation called visceral adiposity index (VAI) has been widely used in assessing cardiometabolic risk. This study aimed at comparing the VAI values of patients with PCOS, patients with idiopathic hir-sutism (IH) and a control group.PATIENTS AND METHODS: We obtained de-mographic data, laboratory results and anthro-pometric measurements of patients from the hospital database. We retrospectively grouped all cases included in the study as PCOS (n = 52), IH (n = 57) and control (n = 58) according to the diagnoses. We also took venous samples for hormone and biochemical tests in the early fol-licular phase of the menstrual cycle, at least 8-10 hours after fasting in the early morning hours. Finally, we evaluated the variables using SPSS 22.0 software (IBM Corp., Armonk, NY, USA).RESULTS: We included 167 female individu-als in the study. Of these, 57 (34.1%) were diag-nosed with IH, while 52 (31.1%) were diagnosed with PCOS. The control group comprised 58 (34.8%) healthy female individuals. The medi-an age of the study group was 25 years [inter -quartile range (IQR) = 8 years]. The age, height, weight, body mass index (BMI) and waist cir-cumference values of the groups were similar. We found that the VAI values among the groups were significantly different (p = 0.028). Post-hoc analysis determined that this was due to the dif-ference between the group with PCOS and the control group. In addition, we found significantly high HOMA-IR, fasting insulin and androgen levels in the group with PCOS (p < 0.001).CONCLUSIONS: After comparing data in groups with similar BMI levels, we found signifi-cantly high VAI values in patients with PCOS. The results reinforce the idea that VAI is a use-ful marker easily obtained in daily practice for assessing the cardiometabolic risk of patients with PCOS.
- Open Access
- 30 April 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (2) , 766-771
The effects of salt consumption habits on iodine status and thyroid functions during pregnancy
Iodine is the basic substrate for thyroid hormone synthesis and is vital for the general population and especially pregnant women. Iodine deficiency may cause severe health problems for a foetus. This study aimed to determine the relationship, if any, between iodine level and thyroid function tests, and to determine the relationship between consumption of salt types and its effects on thyroid function tests in the first trimester of pregnancy. Three hundred and six pregnant women in the first trimester of pregnancy, who had known no thyroid disease history and had not received iodine supportive therapy, were included in the study. All patients were questioned for their preferred table salt or rock salt in daily use and Urine Iodine Concentrations (UIC) were analysed in spot urine. The results were evaluated statistically according to salt usage preferences. The median age of patients in the study was 27.8 (± 5.4). In terms of salt consumption habits, 235 (76.8%) of patients reported using table salt, and 71 (23.2%) reported using rock salt. Iodine deficiency was found in 75.81% (n = 232) of all cases according to urinalysis. Median UIC of table salt group were significantly higher than rock salt group (123.7 ?g/L and 70.9 ?g/L respectively, p<0.001). Although large-scale salt iodination began long time ago, iodine deficiency is still a serious health problem among pregnant women. According to this study, use of rock salt is associated with low urinary iodine concentration in pregnant women and TSH values within the reference limits are not a good indicator for determining the iodine level.
- 30 April 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (2) , 766-771
Open AccessThe effects of salt consumption habits on iodine status and thyroid functions during pregnancy
Iodine is the basic substrate for thyroid hormone synthesis and is vital for the general population and especially pregnant women. Iodine deficiency may cause severe health problems for a foetus. This study aimed to determine the relationship, if any, between iodine level and thyroid function tests, and to determine the relationship between consumption of salt types and its effects on thyroid function tests in the first trimester of pregnancy. Three hundred and six pregnant women in the first trimester of pregnancy, who had known no thyroid disease history and had not received iodine supportive therapy, were included in the study. All patients were questioned for their preferred table salt or rock salt in daily use and Urine Iodine Concentrations (UIC) were analysed in spot urine. The results were evaluated statistically according to salt usage preferences. The median age of patients in the study was 27.8 (± 5.4). In terms of salt consumption habits, 235 (76.8%) of patients reported using table salt, and 71 (23.2%) reported using rock salt. Iodine deficiency was found in 75.81% (n = 232) of all cases according to urinalysis. Median UIC of table salt group were significantly higher than rock salt group (123.7 ?g/L and 70.9 ?g/L respectively, p<0.001). Although large-scale salt iodination began long time ago, iodine deficiency is still a serious health problem among pregnant women. According to this study, use of rock salt is associated with low urinary iodine concentration in pregnant women and TSH values within the reference limits are not a good indicator for determining the iodine level.